Frequently Asked Questions About FOGCF

What does Avisa Diagnostics Inc. do?

Avisa Diagnostics Inc. (FOGCF) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is FOGCF's market cap?

Avisa Diagnostics Inc. (FOGCF) has a market capitalization of approximately $97,176, as of April 21, 2026, based on the most recent share price and shares outstanding.

Does FOGCF pay a dividend?

No — Avisa Diagnostics Inc. (FOGCF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is FOGCF profitable?

Avisa Diagnostics Inc. (FOGCF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

FOGCF (Avisa Diagnostics Inc.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

FOGCF

Avisa Diagnostics Inc.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$97.18K·Market closed·Apr 21 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−100.00%CAGR −87.61%

Select date range

FromTo

Feb 17, 2021Jul 22, 2021 → Jul 22, 2026· 5.0 yrsJul 22, 2026

Key Metrics

FOGCF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how FOGCF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FOGCF and 80,000+ other tickers.

About Avisa Diagnostics Inc.

Avisa Diagnostics Inc. is a medical device company currently in its clinical development phase. The company is advancing the Avisa BreathTest, an innovative drug-device biomarker platform. This technology enables the exceptionally rapid identification and quantitative monitoring of virulent bacterial pathogens, activated when patients inhale or ingest its proprietary diagnostic compounds. Avisa Diagnostics has successfully established clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and community-acquired pneumonia. Currently, the firm is concentrating its efforts on…

CEO: David S. Joseph
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: OTC
Employees: 3
Website: www.avisadx.com

Peers

Peers Tab

BJTRF

Beijing Tong Ren Tang Chinese Medicine Company Limited

Cap

$542.8M

ELTP

Elite Pharmaceuticals, Inc.

Cap

$409.3M

BPMUF

Basilea Pharmaceutica AG

Cap

$746.0M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About FOGCF

What does Avisa Diagnostics Inc. do?: Avisa Diagnostics Inc. (FOGCF) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is FOGCF's market cap?: Avisa Diagnostics Inc. (FOGCF) has a market capitalization of approximately $97,176, as of April 21, 2026, based on the most recent share price and shares outstanding.
Does FOGCF pay a dividend?: No — Avisa Diagnostics Inc. (FOGCF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is FOGCF profitable?: Avisa Diagnostics Inc. (FOGCF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.